#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	19	4172	16S	1529	1529	100.0	16S.l15.c4.ctg.1	2496	462.3	1	SNP	n	C1184T	0	.	.	1184	1184	C	1658	1658	C	533	C	419	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	7348	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3857	526.1	0	.	n	.	0	T695C	SNP	695	695	T	1145	1145	C	527	C,A	422,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	7348	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3857	526.1	0	.	n	.	0	G1337A	SNP	1337	1337	G	1787	1787	A	569	A,C	458,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	7348	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3857	526.1	0	.	n	.	0	T1971C	SNP	1971	1971	T	2421	2421	C	556	C	450	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	7348	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3857	526.1	1	SNP	n	A2045G	0	.	.	2045	2045	A	2495	2495	A	612	A	480	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	7348	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3857	526.1	1	SNP	n	C2597T	0	.	.	2597	2597	C	3047	3047	C	553	C,A,T	436,1,1	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
blaTEM.WHO_M_pConjugative_00003	blaTEM.WHO_M_pConjugative_00003	1	0	27	6102	blaTEM	861	861	100.0	blaTEM.l6.c4.ctg.1	1862	909.5	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Betalactam resistance
folP.WHO_W_01420c	folP.WHO_W_01420c	1	1	539	568	folP	852	852	99.88	folP.l15.c4.ctg.1	1886	83.7	0	.	p	.	0	E151K	NONSYN	451	453	GAA	1010	1012	AAA	116;115;115	A,C;A;A	100,1;95;101	.	.
folP.WHO_W_01420c	folP.WHO_W_01420c	1	1	539	568	folP	852	852	99.88	folP.l15.c4.ctg.1	1886	83.7	1	SNP	p	R228S	1	.	.	682	684	AGC	1241	1243	AGC	110;108;107	A;G;C	86;81;80	folP.WHO_W_01420c:1:1:R228S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	1396	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3721	104.0	1	SNP	p	S91F	0	.	.	271	273	TCC	754	756	TCC	111;111;111	T;C;C	78;80;82	gyrA.WHO_F_00668c:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	1396	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3721	104.0	1	SNP	p	D95N	0	.	.	283	285	GAC	766	768	GAC	111;113;113	G;A,C;C	80;80,1;77	gyrA.WHO_F_00668c:1:1:D95N:gyrA.95N:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	1396	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3721	104.0	1	SNP	p	D95G	0	.	.	283	285	GAC	766	768	GAC	111;113;113	G;A,C;C	80;80,1;77	gyrA.WHO_F_00668c:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
mtrR.WHO_L_00489c	mtrR.WHO_L_00489c	1	1	539	504	mtrR	633	633	99.21	mtrR.l15.c4.ctg.1	1844	76.1	0	.	p	.	0	A39T	NONSYN	115	117	GCC	703	705	ACC	125;125;125	A;C;C	93;94;96	.	.
mtrR.WHO_L_00489c	mtrR.WHO_L_00489c	1	1	539	504	mtrR	633	633	99.21	mtrR.l15.c4.ctg.1	1844	76.1	0	.	p	.	0	I196fs	FSHIFT	586	586	A	1174	1174	A	162	A	122	.	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	19	312	mtrR_promoter	250	250	100.0	mtrR_promoter.l15.c4.ctg.1	1230	68.7	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	1440	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3435	117.4	1	SNP	p	D86N	0	.	.	256	258	GAC	815	817	GAC	148;151;152	G;A;C	120;119;123	parC.WHO_P_00203c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	1440	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3435	117.4	1	SNP	p	S87I	0	.	.	259	261	AGT	818	820	AGT	152;153;155	A,C;G;T	115,1;125;122	parC.WHO_P_00203c:1:1:S87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	1440	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3435	117.4	1	SNP	p	S87R	0	.	.	259	261	AGT	818	820	AGT	152;153;155	A,C;G;T	115,1;125;122	parC.WHO_P_00203c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	1440	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3435	117.4	1	SNP	p	S87W	0	.	.	259	261	AGT	818	820	AGT	152;153;155	A,C;G;T	115,1;125;122	parC.WHO_P_00203c:1:1:S87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	1440	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3435	117.4	1	SNP	p	S88P	0	.	.	262	264	TCC	821	823	TCC	155;155;155	T;C;C	124;122;126	parC.WHO_P_00203c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	1128	parE	1986	1986	100.0	parE.l15.c4.ctg.1	3026	103.7	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1730	1732	GGC	141;137;137	G;G;C	111;110;108	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.4.001	penA.4.001	1	1	27	1086	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2716	111.0	1	SNP	p	A311V	0	.	.	931	933	GCA	1413	1415	GCA	121;119;118	G;C;A	96;92;92	penA.4.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.4.001	penA.4.001	1	1	27	1086	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2716	111.0	1	SNP	p	I312M	0	.	.	934	936	ATC	1416	1418	ATC	118;118;118	A;T;C	93;90;97	penA.4.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.4.001	penA.4.001	1	1	27	1086	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2716	111.0	1	SNP	p	V316T	0	.	.	946	948	GTG	1428	1430	GTG	115;115;115	G;T;G	93;88;90	penA.4.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.4.001	penA.4.001	1	1	27	1086	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2716	111.0	1	SNP	p	V316P	0	.	.	946	948	GTG	1428	1430	GTG	115;115;115	G;T;G	93;88;90	penA.4.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.4.001	penA.4.001	1	1	27	1086	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2716	111.0	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1932	1934	ACC	117;117;114	A,C;C;C	94,1;95;97	penA.4.001:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.4.001	penA.4.001	1	1	27	1086	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2716	111.0	1	SNP	p	A502P	0	.	.	1504	1506	GCG	1986	1988	GCG	118;118;118	G;C,G;G,T	93;82,1;87,1	penA.4.001:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.4.001	penA.4.001	1	1	27	1086	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2716	111.0	1	SNP	p	A502V	0	.	.	1504	1506	GCG	1986	1988	GCG	118;118;118	G;C,G;G,T	93;82,1;87,1	penA.4.001:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.4.001	penA.4.001	1	1	27	1086	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2716	111.0	1	SNP	p	G543S	1	.	.	1627	1629	AGC	2109	2111	AGC	129;127;128	A;G,C;C	105;104,1;106	penA.4.001:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.4.001	penA.4.001	1	1	27	1086	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2716	111.0	1	SNP	p	G546S	0	.	.	1636	1638	GGC	2118	2120	GGC	123;121;122	G;G;C	103;101;102	penA.4.001:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.4.001	penA.4.001	1	1	27	1086	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2716	111.0	1	SNP	p	P552S	0	.	.	1654	1656	CCG	2136	2138	CCG	125;126;126	C,G;C;G,C	105,1;105;100,1	penA.4.001:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	1450	ponA	2397	2397	99.96	ponA.l6.c4.ctg.1	3380	117.8	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
porA.NCCP11945	porA.NCCP11945	1	0	531	740	porA	1146	1146	99.83	porA.l15.c4.ctg.1	2301	90.2	0	.	p	.	0	M83fs	FSHIFT	247	247	A	807	807	C	114	C,T,G	88,1,1	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	68	porB1a	984	287	90.03	porB1a.l6.c17.ctg.1	1311	13.9	0	.	p	.	0	H217N	NONSYN	649	651	CAT	1046	1048	AAT	10;10;10	A;A;T	7;7;7	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	68	porB1a	984	287	90.03	porB1a.l6.c17.ctg.1	1311	13.9	0	.	p	.	0	D218N	NONSYN	652	654	GAT	1049	1051	AAT	10;10;10	A;A;T	7;7;7	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	68	porB1a	984	287	90.03	porB1a.l6.c17.ctg.1	1311	13.9	0	.	p	.	0	V226A	NONSYN	676	678	GTA	1073	1075	GCA	10;10;10	G;C;A	7;7;7	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	68	porB1a	984	287	90.03	porB1a.l6.c17.ctg.1	1311	13.9	0	.	p	.	0	.	MULTIPLE	700	702	ACT	1096	1098	GTA	10;10;10	G;T;A	7;7;7	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	68	porB1a	984	287	90.03	porB1a.l6.c17.ctg.1	1311	13.9	0	.	p	.	0	S236N	NONSYN	706	708	AGC	1102	1104	AAC	10;10;10	A;A;C	7;7;7	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	68	porB1a	984	287	90.03	porB1a.l6.c17.ctg.1	1311	13.9	0	.	p	.	0	.	MULTIPLE	709	711	AAC	1106	1110	TGGCG	10;10;10;10;10	T;G;G;C;G	7;7;7;7;7	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	68	porB1a	984	287	90.03	porB1a.l6.c17.ctg.1	1311	13.9	0	.	p	.	0	D238A	NONSYN	712	714	GAT	1112	1114	GCT	10;10;10	G;C;T	7;7;7	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	68	porB1a	984	287	90.03	porB1a.l6.c17.ctg.1	1311	13.9	0	.	p	.	0	A251V	NONSYN	751	753	GCG	1151	1153	GTA	9;9;9	G;T;A	7;7;7	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	68	porB1a	984	287	90.03	porB1a.l6.c17.ctg.1	1311	13.9	0	.	p	.	0	S271T	NONSYN	811	813	TCG	1211	1213	ACT	9;9;9	A;C;T	7;7;7	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	68	porB1a	984	287	90.03	porB1a.l6.c17.ctg.1	1311	13.9	0	.	p	.	0	Y273D	NONSYN	817	819	TAT	1217	1219	GAT	9;9;9	G;A;T	7;7;7	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	68	porB1a	984	287	90.03	porB1a.l6.c17.ctg.1	1311	13.9	0	.	p	.	0	D276N	NONSYN	826	828	GAT	1226	1228	AAC	9;9;9	A;A;C	7;7;7	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	68	porB1a	984	287	90.03	porB1a.l6.c17.ctg.1	1311	13.9	0	.	p	.	0	N277H	NONSYN	829	831	AAC	1229	1231	CAC	9;9;9	C;A;C	7;7;7	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	68	porB1a	984	287	90.03	porB1a.l6.c17.ctg.1	1311	13.9	0	.	p	.	0	S297Y	NONSYN	889	891	TCT	1289	1291	TAT	9;9;9	T;A,C;T	7;0,6;6	.	.
porB1b.WHO_O_01976	porB1b.WHO_O_01976	1	1	795	852	porB1b	1041	1041	99.42	porB1b.l6.c17.ctg.1	1994	117.3	0	.	p	.	0	T26A	NONSYN	76	78	ACC	795	797	GCC	166;168;168	G,T;C;C	127,4;130;133	.	.
porB1b.WHO_O_01976	porB1b.WHO_O_01976	1	1	795	852	porB1b	1041	1041	99.42	porB1b.l6.c17.ctg.1	1994	117.3	0	.	p	.	0	K41D	NONSYN	121	123	AAA	840	842	GAC	162;162;161	G;A;C	128;130;127	.	.
porB1b.WHO_O_01976	porB1b.WHO_O_01976	1	1	795	852	porB1b	1041	1041	99.42	porB1b.l6.c17.ctg.1	1994	117.3	1	SNP	p	G120K	1	.	.	358	360	AAG	1077	1079	AAG	172;172;171	A;A;G,C	140;143;135,1	porB1b.WHO_O_01976:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_O_01976	porB1b.WHO_O_01976	1	1	795	852	porB1b	1041	1041	99.42	porB1b.l6.c17.ctg.1	1994	117.3	1	SNP	p	D121N	0	.	.	361	363	GAC	1080	1082	GAC	172;173;175	G;A,T,C;C	142;141,1,1;139	porB1b.WHO_O_01976:1:1:D121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_O_01976	porB1b.WHO_O_01976	1	1	795	852	porB1b	1041	1041	99.42	porB1b.l6.c17.ctg.1	1994	117.3	1	SNP	p	A121D	1	.	.	361	363	GAC	1080	1082	GAC	172;173;175	G;A,T,C;C	142;141,1,1;139	porB1b.WHO_O_01976:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_F_02153c	rpoB.WHO_F_02153c	1	1	539	2576	rpoB	4179	4179	99.98	rpoB.l15.c4.ctg.1	5190	138.7	1	SNP	p	H553N	1	H553N	NONSYN	1657	1659	CAT	2173	2175	AAT	132;131;129	A;A;T	109;108;103	rpoB.WHO_F_02153c:1:1:H553N:rpoB.553N:H552N. High-level resistance to Rifampicin	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	416	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1547	75.9	1	SNP	p	V57M	1	.	.	169	171	ATG	792	794	ATG	190;190;189	A;T;G	142;142;139	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
